Lobeglitazone Completed Phase 1 Trials for Type 2 Diabetes Mellitus Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01330563Drug-drug Interaction Study (CKD-501, Ketoconazole)
NCT01341392Drug-drug Interaction Study(CKD-501, Amlodipine)
NCT02002611Drug-drug Interaction Study(Lobeglitazone, Warfarin)
NCT02827890CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)
NCT03616392Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308
NCT02824874CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1)